AR015347A1 - Uso de colina para la preparacion de un medicamento o formulacion nutricional para el tratamiento del shock endotoxico y composiciones nutricionales quecomprenden colina - Google Patents

Uso de colina para la preparacion de un medicamento o formulacion nutricional para el tratamiento del shock endotoxico y composiciones nutricionales quecomprenden colina

Info

Publication number
AR015347A1
AR015347A1 ARP980100246A ARP980100246A AR015347A1 AR 015347 A1 AR015347 A1 AR 015347A1 AR P980100246 A ARP980100246 A AR P980100246A AR P980100246 A ARP980100246 A AR P980100246A AR 015347 A1 AR015347 A1 AR 015347A1
Authority
AR
Argentina
Prior art keywords
hill
nutritional
preparation
treatment
endotoxic shock
Prior art date
Application number
ARP980100246A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR015347A1 publication Critical patent/AR015347A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de colina en la preparacion de un medicamento o formulacion nutritiva, para la reduccion y/o la prevencion de lesion y/o mortalidad inducidas porendotoxina, util para el tratamiento de choque endotoxico, el cual comprende, una cantidad efectivad e colina, para reducir la lesion y la mortalidad inducidaspor endotoxina. La composicion nutritiva comprende colina, en donde la composicion proporciona, en una forma de dosificacion diaria, de 1,5 a 20 gramos decolina y/o en asociacion con uno omás componentes.
ARP980100246A 1997-01-27 1998-01-20 Uso de colina para la preparacion de un medicamento o formulacion nutricional para el tratamiento del shock endotoxico y composiciones nutricionales quecomprenden colina AR015347A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/789,773 US6013273A (en) 1997-01-27 1997-01-27 Treatment of endotoxic shock

Publications (1)

Publication Number Publication Date
AR015347A1 true AR015347A1 (es) 2001-05-02

Family

ID=25148643

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100246A AR015347A1 (es) 1997-01-27 1998-01-20 Uso de colina para la preparacion de un medicamento o formulacion nutricional para el tratamiento del shock endotoxico y composiciones nutricionales quecomprenden colina

Country Status (7)

Country Link
US (1) US6013273A (es)
EP (1) EP0957904A2 (es)
JP (1) JP2001508781A (es)
AR (1) AR015347A1 (es)
AU (1) AU6212598A (es)
WO (1) WO1998032428A2 (es)
ZA (1) ZA98603B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
US8100879B2 (en) 2002-11-18 2012-01-24 Nestec S.A. Connector device for enteral administration set
DE10257360A1 (de) * 2002-12-09 2004-07-08 Fresenius Kabi Deutschland Gmbh Gastro-intestinal verabreichbare Formulierung und deren Verwendung
EP1605781A1 (en) * 2003-03-18 2005-12-21 Novartis AG Compositions comprising fatty acids and amino acids
US6897412B1 (en) * 2004-01-27 2005-05-24 Agilent Technologies, Inc. Inward opening oven intake for gas chromatographic oven
EP1591118A1 (en) * 2004-04-27 2005-11-02 Nutri-Fit GmbH & Co. KG Use of melatonin in preventing postoperative complications
CH705786B1 (de) 2011-11-18 2015-08-14 Pavatex Sa Nut-Kamm-Verbindung, insbesondere für Faserplatten für eine verfalzt gestossene Fläche.
ITMI20122088A1 (it) * 2012-12-06 2014-06-07 D M F Dietetic Metabolic Food S R L Composizione per la prevenzione ed il trattamento della steatosi epatica e/o della fibrosi cistica
AU2014338503A1 (en) * 2013-10-21 2016-03-31 Enzymotec Ltd. Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
EP3285602A1 (en) * 2015-04-21 2018-02-28 Enzymotec Ltd. Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB915813A (en) * 1959-12-31 1963-01-16 Biorex Laboratories Ltd Anti-anaphylactic compositions comprising alkanolamines and derivatives thereof
CA1114295A (en) * 1977-11-02 1981-12-15 John H. Growdon Process and composition for treating disorders by administering choline or a compound that dissociates to choline
US4626527A (en) * 1985-09-28 1986-12-02 Massachusetts Institute Of Technology Process for utilizing choline to sustain muscular performance
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US5374651A (en) * 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
US5284835A (en) * 1992-07-31 1994-02-08 Lieber Charles S Use of dilinoleoylphosphatidylcholine (DLPC) for treatment and prevention of cirrhosis and fibrosis in the liver

Also Published As

Publication number Publication date
WO1998032428A2 (en) 1998-07-30
EP0957904A2 (en) 1999-11-24
ZA98603B (en) 1998-07-27
US6013273A (en) 2000-01-11
AU6212598A (en) 1998-08-18
WO1998032428A3 (en) 1998-11-12
JP2001508781A (ja) 2001-07-03

Similar Documents

Publication Publication Date Title
AR015347A1 (es) Uso de colina para la preparacion de un medicamento o formulacion nutricional para el tratamiento del shock endotoxico y composiciones nutricionales quecomprenden colina
BR0107535A (pt) Uso de carotenóides e forma de dosagem unitária destes
DE60127457D1 (de) Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
BG104680A (en) Celecoxib compositions
WO2006017692A3 (en) Novel fenofibrate formulations and related methods of treatment
ES2148838T3 (es) Oligonucleotidos antisentido contra la subunidad reguladora alfa de la proteina quinasa dependiente de camp para el tratamiento del cancer.
AR035001A1 (es) Composiciones farmaceuticas de administracion oral, que contienen un inhibidor de lipasa gastrointestinal, el comprimido masticable y el uso de dichos compuestos para preparar un medicamento
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
DE69114498D1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
EP1745797A3 (en) Vascularization inhibitors
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
CA2173147A1 (en) Anti-obesity agent
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
CL2004001365A1 (es) Compuestos derivados de 3-fluoropiperidina; composicion farmaceutica que lo comprende; y uso del compuesto para tratar o prevenir el dolor o la enfermedad de parkinson.
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
BR0107960A (pt) Tratamento de condições alérgicas e inflamatórias
UY26376A1 (es) Combinaciones sinteticas de un antagonista de nk1 y un analogo estructural de gaba
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
DE69117303D1 (de) Zusammensetzung mit psyllium
CA2385755A1 (en) Prevention of colorectal cancer
AR029451A1 (es) Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
PL1694320T3 (pl) Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności
ATE380543T1 (de) Stabilisierung von festen schilddrüsenhormonzusammensetzungen
AR007059A1 (es) Uso de interferon en la preparacion de medicamentos y composiciones via oromucosal o por contacto

Legal Events

Date Code Title Description
FB Suspension of granting procedure